Brian Cheng
Stock Analyst at J.P. Morgan
(4.41)
# 1,155
Out of 4,455 analysts
251
Total ratings
54.8%
Success rate
11.1%
Average return
Main Sectors:
Stocks Rated by Brian Cheng
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RVMD Revolution Medicines | Reiterated: Buy | $200 | $182.08 | +9.84% | 14 | Jun 25, 2026 | |
| KYMR Kymera Therapeutics | Maintained: Buy | n/a | $108.12 | - | 6 | Jun 25, 2026 | |
| IMNM Immunome | Reiterated: Buy | $39 | $19.96 | +95.39% | 8 | Jun 12, 2026 | |
| ODTX Odyssey Therapeutics | Initiated Coverage: Buy | $26 | $18.13 | +43.41% | 1 | Jun 2, 2026 | |
| EIKN Eikon Therapeutics | Maintained: Buy | n/a | $11.45 | - | 4 | May 31, 2026 | |
| TGTX TG Therapeutics | Reiterated: Buy | n/a | $55.83 | - | 2 | May 27, 2026 | |
| IMVT Immunovant | Maintained: Buy | $35 → $47 | $38.85 | +20.98% | 11 | May 26, 2026 | |
| ROIV Roivant Sciences | Maintained: Buy | $35 → $40 | $34.07 | +17.41% | 23 | May 26, 2026 | |
| TARA Protara Therapeutics | Maintained: Buy | $26 | $4.12 | +531.07% | 4 | May 18, 2026 | |
| NTLA Intellia Therapeutics | Maintained: Sell | $8 | $16.68 | -52.04% | 17 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $106 → $113 | $121.88 | -7.29% | 22 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $29 | $8.44 | +243.60% | 8 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $80 → $89 | $84.43 | +5.41% | 9 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $13 → $14 | $15.05 | -6.98% | 15 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $30 → $31 | $22.29 | +39.08% | 2 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $96 | $71.96 | +33.41% | 9 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $88 | $78.89 | +11.55% | 1 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $2.13 | - | 8 | Apr 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $47 → $46 | $16.72 | +175.12% | 6 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $34.81 | - | 5 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $2.85 | - | 7 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $24.15 | - | 13 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $69 → $67 | $54.92 | +22.00% | 3 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $1.14 | - | 2 | Dec 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $1.53 | - | 1 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $10.89 | - | 1 | Oct 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $5.86 | - | 6 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.02 | n/a | 8 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.68 | n/a | 7 | Sep 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1.50 | n/a | 1 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $16 → $6 | $1.25 | n/a | 2 | May 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $20 → $6 | $8.37 | n/a | 3 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $1.09 | n/a | 1 | Dec 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $0.157 | n/a | 5 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 → $3.5 | $1.53 | n/a | 2 | Apr 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 → $17 | $9.94 | n/a | 6 | Apr 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $1.08 | n/a | 1 | Apr 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $93 → $86 | $6.88 | n/a | 5 | Mar 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $3.05 | n/a | 2 | Nov 2, 2021 |
Revolution Medicines
Jun 25, 2026
Reiterated: Buy
Price Target: $200
Current: $182.08
Upside: +9.84%
Kymera Therapeutics
Jun 25, 2026
Maintained: Buy
Price Target: n/a
Current: $108.12
Upside: -
Immunome
Jun 12, 2026
Reiterated: Buy
Price Target: $39
Current: $19.96
Upside: +95.39%
Odyssey Therapeutics
Jun 2, 2026
Initiated Coverage: Buy
Price Target: $26
Current: $18.13
Upside: +43.41%
Eikon Therapeutics
May 31, 2026
Maintained: Buy
Price Target: n/a
Current: $11.45
Upside: -
TG Therapeutics
May 27, 2026
Reiterated: Buy
Price Target: n/a
Current: $55.83
Upside: -
Immunovant
May 26, 2026
Maintained: Buy
Price Target: $35 → $47
Current: $38.85
Upside: +20.98%
Roivant Sciences
May 26, 2026
Maintained: Buy
Price Target: $35 → $40
Current: $34.07
Upside: +17.41%
Protara Therapeutics
May 18, 2026
Maintained: Buy
Price Target: $26
Current: $4.12
Upside: +531.07%
Intellia Therapeutics
May 13, 2026
Maintained: Sell
Price Target: $8
Current: $16.68
Upside: -52.04%
May 13, 2026
Maintained: Buy
Price Target: $106 → $113
Current: $121.88
Upside: -7.29%
May 13, 2026
Rated: Buy
Price Target: $29
Current: $8.44
Upside: +243.60%
May 11, 2026
Maintained: Buy
Price Target: $80 → $89
Current: $84.43
Upside: +5.41%
May 11, 2026
Rated: Hold
Price Target: $13 → $14
Current: $15.05
Upside: -6.98%
May 11, 2026
Rated: Buy
Price Target: $30 → $31
Current: $22.29
Upside: +39.08%
May 11, 2026
Rated: Buy
Price Target: $96
Current: $71.96
Upside: +33.41%
May 1, 2026
Initiated Coverage: Buy
Price Target: $88
Current: $78.89
Upside: +11.55%
Apr 16, 2026
Upgraded: Hold
Price Target: n/a
Current: $2.13
Upside: -
Apr 15, 2026
Maintained: Buy
Price Target: $47 → $46
Current: $16.72
Upside: +175.12%
Mar 25, 2026
Maintained: Buy
Price Target: n/a
Current: $34.81
Upside: -
Mar 13, 2026
Maintained: Sell
Price Target: n/a
Current: $2.85
Upside: -
Mar 3, 2026
Maintained: Buy
Price Target: n/a
Current: $24.15
Upside: -
Feb 13, 2026
Maintained: Buy
Price Target: $69 → $67
Current: $54.92
Upside: +22.00%
Dec 4, 2025
Reiterated: Sell
Price Target: n/a
Current: $1.14
Upside: -
Nov 20, 2025
Initiated Coverage: Hold
Price Target: n/a
Current: $1.53
Upside: -
Oct 2, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $10.89
Upside: -
Aug 15, 2025
Upgraded: Hold
Price Target: n/a
Current: $5.86
Upside: -
Mar 21, 2025
Rated: Hold
Price Target: n/a
Current: $1.02
Upside: n/a
Sep 13, 2024
Rated: Hold
Price Target: n/a
Current: $3.68
Upside: n/a
Jul 15, 2024
Maintained: Hold
Price Target: n/a
Current: $1.50
Upside: n/a
May 2, 2024
Downgraded: Hold
Price Target: $16 → $6
Current: $1.25
Upside: n/a
Jun 1, 2023
Downgraded: Hold
Price Target: $20 → $6
Current: $8.37
Upside: n/a
Dec 16, 2022
Initiated Coverage: Hold
Price Target: n/a
Current: $1.09
Upside: n/a
Dec 7, 2022
Downgraded: Sell
Price Target: n/a
Current: $0.157
Upside: n/a
Apr 19, 2022
Maintained: Buy
Price Target: $33 → $3.5
Current: $1.53
Upside: n/a
Apr 8, 2022
Reiterated: Buy
Price Target: $21 → $17
Current: $9.94
Upside: n/a
Apr 4, 2022
Reiterated: Buy
Price Target: $12
Current: $1.08
Upside: n/a
Mar 1, 2022
Maintained: Buy
Price Target: $93 → $86
Current: $6.88
Upside: n/a
Nov 2, 2021
Maintained: Buy
Price Target: $14
Current: $3.05
Upside: n/a